Association between Impaired Insulin Sensitivity and StrokeBravata D.M.a, b, d · Wells C.K.a, d · Kernan W.N.d · Concato J.a, b, d · Brass L.M.c, e · Gulanski B.I.b, d
aClinical Epidemiology Research Center (CERC), bMedicine Service, and cNeurology Service, VA Connecticut Healthcare System, West Haven, Conn., dDepartment of Internal Medicine, and eDepartment of Neurology, Yale University School of Medicine, New Haven, Conn., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Background: Prior research has indicated an association between insulin resistance and stroke; we sought to determine if this association persists after adjusting for stroke risk factors, including glycemic control. Methods: We used data from the Third National Health and Nutrition Survey (1988–1994), including participants aged ≧40 years. We assessed insulin sensitivity using the homeostasis model assessment (HOMA): HOMA = (FPGSI × FPI)/22.5, where FPGSI refers to fasting plasma glucose (mmol/l) and FPI refers to fasting plasma insulin (µU/l). Increasing HOMA indicates decreasing insulin sensitivity. We used glycosylated hemoglobin (HbA1c) to measure glycemic control. Multivariable logistic regression analysis was used to identify factors that were independently associated with stroke. Results: Among 3,844 participants, 168 (4%) reported a stroke history. Participants with stroke had lower insulin sensitivity than participants without stroke: HOMA mean ± standard deviation, 4.0 ± 4.0 vs. 3.3 ± 3.0; p = 0.022. HOMA was independently associated with stroke (odds ratio 1.06, 95% CI: 1.01–1.12; adjusted for age, hypertension, myocardial infarction, claudication, activity, and HbA1c). The strength of the association between HOMA and stroke was similar to the association between claudication and stroke (index R2: 0.0032 vs. 0.0036). Conclusions: Impaired insulin sensitivity is independently associated with stroke, even after adjustment for glycemic control.
© 2005 S. Karger AG, Basel
- Ninomiya J, L’Italien G, Criqui M, Whyte J, Gamst A, Chen R: Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2003;109:42–46.
- Shinozaki K, Naritomi H, Shimizu T, et al: Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke. Stroke 1996;27:37–43.
- Gertler M, Leetma H, Koutrouby R, Johnson E: The assessment of insulin, glucose and lipids in ischemic thrombotic cerebrovascular disease. Stroke 1975;6:77–84.
- Pyorala M, Miettinen H, Laakso M, Pyorala K: Hyperinsulinemia and the risk of stroke in healthy middle-aged men. The 22-year follow-up results of the Helsinki Policemen Study. Stroke 1998;29:1860–1866.
- Folsom A, Rasmussen M, Chambless L, et al: Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. Diabetes Care 1999;22:1077–1083.
- Matsumoto K, Miyake S, Yano M, et al: Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke. Diabetes Care 1999;22:1191–1195.
- Isomaa B, Almgren P, Tuomi T, et al: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683–689.
- Pyorala M, Miettinen H, Halonen P, Laakso M, Pyorala K: Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: The 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol 2000;20:538–544.
- Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, Horwitz RI: Insulin resistance and risk for stroke. Neurology 2002;59:809–815.
DeFronzo R, Tobin J, Andres R: Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214–E223.
- Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–419.
- Hanson R, Pratley R, Bogardus C, et al: Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 2000;151:190–198.
- Matsuda M, DeFronzo R: Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999;22:1462–1470.
- Harris MI, Flegal KM, Cowie CC, et al: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. Diabetes Care 1998;21:518–524.
Feinstein AR: Multivariable Analysis: An Introduction. New Haven, Yale University Press, 1996.
- Sacco R, Benjamin E, Broderick J, et al: American Heart Association Prevention Conference. 4. Prevention and rehabilitation of stroke: Risk factors. Stroke 1997;28:1507–1517.
- Lehto S, Ronnemaa T, Pyorala K, Laakso M: Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke 1996;27:63–68.
- Wannamethee S, Perry I, Shaper A: Nonfasting serum glucose and insulin concentrations and the risk of stroke. Stroke 1999;30:1780–1786.
- Howard G, O’Leary DH, Zaccaro D, et al: Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996;93:1809–1817.
- Wyller T, Ranhoff A, Bautz-Holter E: Validity of questionnaire information from old people on previous cerebral stroke. Cerebrovasc Dis 1994;4:57–58.
- O’Mahony PG, Dobson R, Rodgers H, James OF, Thomson RG: Validation of a population screening questionnaire to assess prevalence of stroke. Stroke 1995;26:1334–1337.
- Bots ML, Looman SJ, Koudstaal PJ, Hofman A, Hoes AW, Grobbee DE: Prevalence of stroke in the general population. The Rotterdam Study. Stroke 1996;27:1499–1501.
- Horner RD, Cohen HJ, Blazer DG: Accuracy of self-reported stroke among elderly veterans. Aging Ment Health 2001;5:275–281.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.